[1]Siegel R L, Giaquinto A N, Jemal A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1): 12-49.
[2]Zhang L, Ma W, Qiu Z, et al. Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors[J]. Front Immunol, 2023, 14:1219929.
[3]Ma F, Li L, Xu L, et al. The relationship between systemic inflammation index, systemic immune-inflammatory index, and inflammatory prognostic index and 90-day outcomes in acute ischemic stroke patients treated with intravenous thrombolysis[J]. J Neuroinflammation, 2023, 20(1): 220.
[4]Bossi P, Delrio P, Mascheroni A, et al. The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review[J]. Nutrients, 2021,13(6): 1980.
[5]Bye A, Sandmael JA, Stene GB, et al. Exercise and nutrition interventions in patients with head and neck cancer during curative treatment: a systematic review and meta-analysis[J]. Nutrients, 2020,12(11): 3233.
[6]Wang H M, Wang T J, Huang C S, et al. Nutritional status and related factors in patients with gastric cancer after gastrectomy: a cross-sectional study[J]. Nutrients, 2022, 14(13): 2634.
[7]Zaman S, Mohamedahmed A Y Y, Abdelrahman W. Minimally invasive surgery for inflammatory bowel disease: a systematic review and meta-analysis of robotic versus laparoscopic surgical techniques[J]. J Crohns Colitis, 2024, 18(9):1522-1523.
[8]Li S Y, Wan L L, Liu Y F, et al. Prognostic value of three clinical nutrition scoring system (NRI, PNI, and CONUT) in elderly patients with prostate cancer[J]. Front Nutr, 2024, 11: 1436063.
[9]Yang M, Lin S Q, Liu X Y, et al. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study[J]. Front Immunol, 2023, 14: 1131496.
[10]Zhang X, Wei R, Wang X, et al. The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension[J]. Cardiovasc Diabetol, 2024, 23(1): 117.
[11]Liu T, Liu C, Deng L, et al. The prognostic effect of sixteen malnutrition/inflammation-based indicators on the overall survival of chemotherapy patients[J]. Front Immunol, 2023, 14: 1117232.
[12]Zhang Y, Gu D. Prognostic impact of serum CRP level in head and neck squamous cell carcinoma[J]. Frontiers in Oncology, 2022, 12: 889844.
[13]Yu M, Li X, Chen M, et al. Prognostic potential of nutritional risk screening and assessment tools in predicting survival of patients with pancreatic neoplasms: a systematic review[J]. Nutr J, 2024, 23(1): 17.
[14]Ruan G T, Deng L, Xie H L, et al. Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia[J]. Cancer Metab, 2024, 12(1): 3.
[15]Karimi A, Shobeiri P, Kulasinghe A, et al. Novel systemic inflammation markers to predict COVID-19 prognosis[J]. Front Immunol, 2021, 12: 741061.
[16]Bouillanne O, Morineau G, Dupont C, et al. Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients[J]. Am J Clin Nutr, 2005, 82(4): 777-783.
[17]Aprile G, Basile D, Giaretta R, et al. The clinical value of nutritional care before and during active cancer treatment[J]. Nutrients, 2021, 13(4): 1196.
[18]Song G H, Choi H B, Park H C, et al. Geriatric nutritional risk index and first-year mortality in incident hemodialysis patients[J]. Nutrients, 2024, 16(5): 652.
[19]Liu Z, Jin K, Guo M, et al. Prognostic value of the CRP/Alb ratio, a novel inflammation-based score in pancreatic cancer[J]. Ann Surg Oncol, 2016, 24(2): 561-568.
[20]Narimatsu H, Yaguchi Y T. The role of diet and nutrition in cancer: prevention, treatment, and survival[J]. Nutrients, 2022, 14(16): 3329.
[21]Qureshi H A, Abouyared M, Barber B, et al. Surgical options for locally advanced oropharyngeal cancer[J]. Curr Treat Options Oncol, 2019, 20(5): 36.
[22]Hui D, Paiva C E, Del Fabbro E G, et al. Prognostication in advanced cancer: update and directions for future research[J]. Support Care Cancer, 2019, 27(6): 1973-1984.
[23]Zhao C, Guan Z, Jiang Q, et al. Predictive value of PAR and PNI for the acute complicated course of pediatric acute hematogenous osteomyelitis[J]. J Pediatr (Rio J), 2024, 100(5): 533-538.
[24]Xie R, Xiao M, Li L, et al. Association between SII and hepatic steatosis and liver fibrosis: a population-based study[J]. Front Immunol, 2022, 13: 925690.
|